Kallikadan, a highly experienced healthcare professional with over 20 years of world experience, is known for her compassionate care and personal connections with patients
Up to 80% of circulating B12 is in the inactive form
EGCG addresses both pathways simultaneously
Similar to restoring miR-26a expression, EZH2 downregulation inhibited cell growth and cell-cycle progression, whereas EZH2 overexpression rescued the suppressive effect of miR-26a
Key Safety Considerations Despite its biological activity, IGF-1 LR3 raises several concerns: Blood glucose disruption: hypoglycemia is a known risk Fluid retention and musculoskeletal discomfort: commonly reported Metabolic effects: potential insulin resistance with extended exposure Oncogenic signaling: persistently elevated IGF-1 levels have been linked to certain cancers Regulatory Reality Not FDA-approved for therapeutic or lifestyle use Banned in competitive sports by anti-doping agencies Limited clinical evidence: lacks robust, long-term human safety trials A Cautious Outlook While IGF-1 LR3 provides valuable insights into growth factor biology, its translation beyond controlled research environments remains unresolved
Very happy with this one so far